Acquisition of a biotech venture platform through the acquisition of ケセラ社
A standalone M&A transaction to acquire UK biotech venture ケセラ社 and make it a wholly owned subsidiary, incorporating its biotechnology-related business and R&D platform.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.